As of 2025-11-05, the Intrinsic Value of Abivax SA (ABVX.PA) is -14.69 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 88.30 EUR, the upside of Abivax SA is -116.63%.
Based on its market price of 88.30 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 116.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.69 - -14.69 | -14.69 | -116.63% |
| P/E | (9.16) - (17.27) | (11.46) | -113.0% |
| DDM - Stable | (24.03) - (110.39) | (67.21) | -176.1% |
| DDM - Multi | (16.38) - (61.37) | (26.19) | -129.7% |
| Market Cap (mil) | 6,872.39 |
| Beta | 1.24 |
| Outstanding shares (mil) | 77.83 |
| Enterprise Value (mil) | 6,861.37 |
| Market risk premium | 5.82% |
| Cost of Equity | 9.48% |
| Cost of Debt | 5.00% |
| WACC | 9.41% |